The NHS in the UK has reported that an innovative capsule sponge test could effectively diagnose Barrett’s oesophagus, a precursor to oesophageal cancer, in a trial.
The trial has demonstrated the test’s ability to reduce the need for invasive endoscopies among thousands of low-risk patients.
More than 8,500 subjects were tested using the capsule sponge test during the NHS pilot.
The evaluation revealed that nearly eight-in-ten patients who completed the test were discharged without requiring further testing.
